Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in TaxesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Share-based Compensation (2022 - 2025)

Historic Share-based Compensation for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to $696615.4.

  • InflaRx's Share-based Compensation fell 272.67% to $696615.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year increase of 865.04%. This contributed to the annual value of $4.4 million for FY2024, which is 1978.32% up from last year.
  • Latest data reveals that InflaRx reported Share-based Compensation of $696615.4 as of Q3 2025, which was down 272.67% from $1.3 million recorded in Q2 2025.
  • InflaRx's Share-based Compensation's 5-year high stood at $2.8 million during Q1 2022, with a 5-year trough of $363215.6 in Q4 2024.
  • For the 4-year period, InflaRx's Share-based Compensation averaged around $1.3 million, with its median value being $1.1 million (2023).
  • As far as peak fluctuations go, InflaRx's Share-based Compensation tumbled by 5438.73% in 2023, and later surged by 5602.3% in 2024.
  • Over the past 4 years, InflaRx's Share-based Compensation (Quarter) stood at $472716.3 in 2022, then increased by 3.11% to $487398.6 in 2023, then dropped by 25.48% to $363215.6 in 2024, then skyrocketed by 91.79% to $696615.4 in 2025.
  • Its Share-based Compensation stands at $696615.4 for Q3 2025, versus $1.3 million for Q2 2025 and $2.6 million for Q1 2025.